InnerScope Partners with Ainnova Tech in OTCHealth Acquisition

October 29, 2025
InnerScope Hearing Technologies has announced a strategic alliance with Ainnova Tech as part of Ainnova's acquisition of OTCHealth Inc., transitioning retail operations to the new subsidiary and focusing on global R&D and hearing technology innovation.

InnerScope Hearing Technologies announced its participation in the acquisition of OTCHealth Inc. by Ainnova Tech, Inc., according to a press release. The partnership allows InnerScope to leverage its retail distribution network and technology portfolio to enhance access to preventive hearing and health solutions.

As an equity owner in OTCHealth, InnerScope will transfer most of its sales operations, including retail agreements with major U.S. outlets such as Walmart, CVS, Target, and Walgreens, to OTCHealth. The move will enable OTCHealth, now a subsidiary of Ainnova, to expand its reach across more than 15,000 independent pharmacies and healthcare providers nationwide.

Under the agreement, InnerScope will hold equity and profit participation in both OTCHealth and Ainnova following the acquisition. The company will focus on advancing its proprietary hearing technologies, which will be integrated into OTCHealth’s digital health offerings supported by Ainnova’s AI-driven diagnostics platform.

The collaboration aims to combine InnerScope’s hearing care expertise, OTCHealth’s digital health infrastructure, and Ainnova’s AI-based analytics to improve early detection of conditions linked to hearing loss, such as diabetes and cognitive decline.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

10/30
Sam Altman Reportedly Building Ultrasound-Based Brain Interface Startup Merge Labs
10/30
Figma Acquires AI Media Generation Startup Weavy, Launches Figma Weave
10/30
Archy Raises $20M Series B to Expand AI Platform for Dental Practices
10/30
Harvey Raises $150 Million from Andreessen Horowitz at $8 Billion Valuation
10/30
Burkhan Capital Leads $300 Million Investment in Robo.ai

More from: Life Sciences

10/30
Sam Altman Reportedly Building Ultrasound-Based Brain Interface Startup Merge Labs
10/30
Archy Raises $20M Series B to Expand AI Platform for Dental Practices
10/30
Remedy Robotics Unveils AI-Powered Remote Endovascular Surgery System
10/30
Remedy Robotics Partners with Mission Thrombectomy to Expand Global Stroke Treatment Access
10/30
Monteris Medical and Symphony Robotics Partner on AI Micro-Robotic Platform for Brain Surgery

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Governing the Future: A Strategic Framework for AI Adoption in Financial Institutions

This whitepaper explores the transformative impact of artificial intelligence on the financial industry, focusing on the governance challenges and regulatory demands faced by banks. It provides a strategic framework for AI adoption, emphasizing the importance of a unified AI approach to streamline compliance and reduce operational costs. The document offers actionable insights and expert recommendations for banks with fewer than 2,000 employees to become leaders in compliant, customer-centric AI.

Read more

You May Also Like